scorecardresearch
Add as a preferred source on Google
Tuesday, December 9, 2025
TopicNovartis

Topic: Novartis

India approves Zolgensma, one of world’s costliest drugs. Why it’s sparked hope, but also concern

Zolgensma is the only drug that promises a cure for Spinal Muscular Atrophy, provided it is administered to affected children before the symptoms appear.

In Delhi hospitals, thalassemia patients suffer as life-saving Desferal scarce, set to become 50% costlier

Doctors & patients confirm acute shortage of the drug in hospitals, even as manufacturer Novartis maintains there is no shortage in supply.

2 jabs a year to keep bad cholesterol at bay — breakthrough treatment to launch in India this month

Novartis India, the company that has the import and marketing permission for Inclisiran, refused to divulge the price of the drug in India, but market sources say it is going to be Rs 1.2 lakh per jab.

Novartis, Eli Lilly oppose compulsory licences for breast cancer drugs, say sales up despite price

Pharma giants were responding to petition in Kerala HC seeking compulsory licences for their HER2-negative breast cancer drugs, which would allow cheaper, generic versions to be made.

It’ll take more than vaccines to fight Covid, Novartis CEO Narasimhan says

Significant supplies of highly effective vaccines won’t be available until the end of 2021 & even once we have one, it probably won’t protect everyone, Narasimhan said.

On Camera

From Binodini to Mitin—Bengali cinema scripting its comeback this Christmas

As Park Street now anticipates the Christmas lights, Bangla cinema eyes a harmony. Colliding heritage, devotion and some detective grit, the year-ender comes with a rediscovery.

Niti Aayog CEO has a message for power stakeholders. Buckle up for surge to feed EVs, data centres

Clean energy is “no longer the sideshow, it is the show”, BVR Subrahmanyam told the Odisha summit, warning India to lead the global shift or risk others’ tech dominance.

Dubai Tejas crash revives focus on advanced, fully automated safety systems

Dubai airshow crash & pilot death have rekindled concerns over pilot safety, and need for smarter automated systems that can step in when G-forces, temporary loss of consciousness hit the pilot.

Asim Munir & Pakistan’s Failed Marshal Doctrine

None of Pakistan’s PMs has lasted 5 years. That the current PM has given Asim Munir 5 years shows that of all military dictatorships history has seen, Pakistan’s is most creative.